Anne Tuomisto

2.6k citations
50 papers · 1.8k indexed · h-index 20
Topics
Genetic factors in colorectal cancer (12 papers)Inflammatory Biomarkers in Disease Prognosis (12 papers)Cancer Immunotherapy and Biomarkers (10 papers)

In The Last Decade

Anne Tuomisto

47 papers receiving 1.7k citations

Peers

Anne Tuomisto
Comparison fields: 5 of 114
  • Oncology 990
  • Molecular Biology 445
  • Cancer Research 378
  • Immunology 292
  • Pathology and Forensic Medicine 264
Replace Pawan Kumar with:
Pawan Kumar United States
Dietmar Abraham Austria
Seok‐Hyung Kim South Korea
Maria Mitzi Brentani Brazil
Baoqing Jia China
Kirsi‐Maria Haapasaari Finland
Anna Biernacka United States
Wenfeng Cao China
Romaine I. Fernando United States
Anne Tuomisto relative to Pawan Kumar United States Pawan Kumar's profile →
Citations per field
00.5×1.5×1.9×
Pawan Kumar · 1×
Citations per year

Countries citing papers authored by Anne Tuomisto

Since Specialization
Citations

This map shows the geographic impact of Anne Tuomisto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Tuomisto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Tuomisto more than expected).

Fields of papers citing papers by Anne Tuomisto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Tuomisto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Tuomisto. The network helps show where Anne Tuomisto may publish in the future.

Co-authorship network of co-authors of Anne Tuomisto

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Tuomisto. A scholar is included among the top collaborators of Anne Tuomisto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Tuomisto. Anne Tuomisto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 9
5 3
6 2
7 5
8 201
9 62
10 50
11 11
12 69
13 12
14 5
15 200
16 77
17 62
18 18
19 14
20 35

About Anne Tuomisto

Anne Tuomisto is a scholar working on Oncology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (12 papers), Inflammatory Biomarkers in Disease Prognosis (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (990 citations), Cancer Research (378 citations) and Immunology and Allergy (108 citations). Anne Tuomisto has collaborated with scholars based in Finland, United States and Poland. Frequent co-authors include Markus J. Mäkinen, Juha P. Väyrynen, Tuomo J. Karttunen, Jyrki Mäkelä, Kai Klintrup, Karl‐Heinz Herzig, Toni Karhu, Päivi Sirniö, Tiina Kantola and Sara A. Väyrynen. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026